Menu
16/05/2012
New Info Revises Opinion On Cancer Drug
A prostate cancer drug should be given to NHS patients, a health watchdog has said.
The National Institute for Health and Clinical Excellence (Nice) revised its recommendations on the drug Abiratone after fresh information from the manufacturer, Janssen. Experts have welcomed the draft guidance.
The drug, marketed as Zytiga, can extend the lives of late-stage cancer sufferers by more than three months.
Professor Alan Ashworth, chief executive of the Institute of Cancer Research, said: "We are delighted by today's decision to allow patients with advanced prostate cancer to receive abiraterone on the NHS.
"This drug was discovered at the Institute of Cancer Research and is the result of more than two decades of dedicated work by our scientists and collaborators.
"In clinical trials of men with advanced prostate cancer who have already tried chemotherapy, it has been shown to extend life by an average of four months and improve quality of life."
Each year around 37,000 men in the UK are diagnosed with prostate cancer and 10,000 die from the disease. It is the second most common cause of cancer death in men, accounting for 13%.
The Prostate Cancer Charity also welcomed the recommendation, but called for the guidance to be issued across the whole of the UK; Nice covers just England and Wales.
(H)
The National Institute for Health and Clinical Excellence (Nice) revised its recommendations on the drug Abiratone after fresh information from the manufacturer, Janssen. Experts have welcomed the draft guidance.
The drug, marketed as Zytiga, can extend the lives of late-stage cancer sufferers by more than three months.
Professor Alan Ashworth, chief executive of the Institute of Cancer Research, said: "We are delighted by today's decision to allow patients with advanced prostate cancer to receive abiraterone on the NHS.
"This drug was discovered at the Institute of Cancer Research and is the result of more than two decades of dedicated work by our scientists and collaborators.
"In clinical trials of men with advanced prostate cancer who have already tried chemotherapy, it has been shown to extend life by an average of four months and improve quality of life."
Each year around 37,000 men in the UK are diagnosed with prostate cancer and 10,000 die from the disease. It is the second most common cause of cancer death in men, accounting for 13%.
The Prostate Cancer Charity also welcomed the recommendation, but called for the guidance to be issued across the whole of the UK; Nice covers just England and Wales.
(H)
Related UK National News Stories
Click here for the latest headlines.
24 May 2005
Trials for prostate cancer drugs announced
Scientists have announced that they are testing new drugs that could be used to treat advanced prostate cancer. Currently, advanced prostate cancer is treated with hormone therapy. However, this only works for a short period of time, after which there are few other options for the patient, apart from palliative care.
Trials for prostate cancer drugs announced
Scientists have announced that they are testing new drugs that could be used to treat advanced prostate cancer. Currently, advanced prostate cancer is treated with hormone therapy. However, this only works for a short period of time, after which there are few other options for the patient, apart from palliative care.
25 September 2009
Screening For Prostate Cancer 'Remains Controversial'
There is not enough evidence to support routine prostate cancer screening. Two papers published on bmj.com today conclude that there is insufficient evidence to support population-wide screening for prostate cancer using the prostate specific antigen (PSA) test.
Screening For Prostate Cancer 'Remains Controversial'
There is not enough evidence to support routine prostate cancer screening. Two papers published on bmj.com today conclude that there is insufficient evidence to support population-wide screening for prostate cancer using the prostate specific antigen (PSA) test.
09 November 2004
Report highlights successful fight against prostate cancer
Men with prostate cancer are being seen more quickly and receiving better care according to a new report out today. The report sets out progress made following the publication of the NHS Prostate Cancer programme four years ago.
Report highlights successful fight against prostate cancer
Men with prostate cancer are being seen more quickly and receiving better care according to a new report out today. The report sets out progress made following the publication of the NHS Prostate Cancer programme four years ago.
31 October 2005
Call for action on prostate cancer
The leaders of the three main political parties have issued a joint call for greater action to tackle the problem of prostate cancer. Prime Minister Tony Blair, Conservative leader Michael Howard and Liberal Democrat leader Charles Kennedy have all recorded messages of support for the Prostate Cancer Charter for Action.
Call for action on prostate cancer
The leaders of the three main political parties have issued a joint call for greater action to tackle the problem of prostate cancer. Prime Minister Tony Blair, Conservative leader Michael Howard and Liberal Democrat leader Charles Kennedy have all recorded messages of support for the Prostate Cancer Charter for Action.
17 June 2005
New drug raises hope of cancer treatment
A prototype cancer drug, which could help fight a range of cancers, has shown “promising results” in clinical trials. Scientists from the Institute of Cancer Research found that the 17AAG drug selectively and potently blocked the growth of a wide range of common cancer cells.
New drug raises hope of cancer treatment
A prototype cancer drug, which could help fight a range of cancers, has shown “promising results” in clinical trials. Scientists from the Institute of Cancer Research found that the 17AAG drug selectively and potently blocked the growth of a wide range of common cancer cells.
-
Northern Ireland WeatherToday:A showery start with outbreaks most frequent north of Lough Neagh and through the morning, before dwindling during the afternoon as the northwest breezes ease and brighter spells of weak sunshine prosper. Maximum temperature 8 °C.Tonight:A dry night, save for a few light showers around the coasts, with prolonged clear spells and light winds bringing a frosty dawn for many in central and southern parts. Minimum temperature -3 °C.
